Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Girardi, Enrico ^a   Palmieri, Fabrizio ^a   Angeletti, Claudio ^a   Vanacore, Paola ^a   Matteelli, Alberto ^b   Gori, Andrea ^c   Carbonara, Sergio ^d   Ippolito, Giuseppe ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; COMBINATION ANTIRETROVIRAL THERAPY; CONTROLLED STUDY; DRUG USE; FEMALE; HIV ASSOCIATED TUBERCULOSIS; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; TUBERCULOSIS; CD4 LYMPHOCYTE COUNT; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1; ITALY; LUNG TUBERCULOSIS; MICROBIOLOGY; MIDDLE AGED; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; REGRESSION ANALYSIS; SURVIVAL RATE; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REGRESSION ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VIRAL LOAD;

EID: 84859698680     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/931325     Document Type: Article

References (20)

1. Badri M., Wilson D., Wood R., Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study The Lancet 2002 359 9323 2059 2064 (Pubitemid 34680968)
2. Lawn S. D., Badri M., Wood R., Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort AIDS 2005 19 18 2109 2116 (Pubitemid 41668999)
3. Lawn S. D., Myer L., Edwards D., Bekker L. G., Wood R., Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa AIDS 2009 23 13 1717 1725
4. Girardi E., Antonucci G., Vanacore P., Libanore M., Errante I., Matteelli A., Ippolito G., Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection AIDS 2000 14 13 1985 1991
5. Santoro-Lopes G., De Pinho A. M. F., Harrison L. H., Schechter M., Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy Clinical Infectious Diseases 2002 34 4 543 546 (Pubitemid 34112278)
6. Cohen M. S., Chen Y. Q., McCauley M., Gamble T., Hosseinipour M. C., Kumarasamy N., Hakim J. G., Kumwenda J., Grinsztejn B., Pilotto J. H.S., Godbole S. V., Mehendale S., Chariyalertsak S., Santos B. R., Mayer K. H., Hoffman I. F., Eshleman S. H., Piwowar-Manning E., Wang L., Makhema J., Mills L. A., De Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T. E., Nielsen-Saines K., Celentano D., Essex M., Fleming T. R., Prevention of HIV-1 infection with early antiretroviral therapy The New England Journal of Medicine 2011 365 6 493 505
7. Girardi E., Sabin C. A., Monferte A. D., Hogg B., Phillips A. N., Gill M. J., Dabis F., Reiss P., Kirk O., Bemasconi E., Grabar S., Justice A., Staszewski S., Ftkenheuer G., Sterne J. A. C., Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Clinical Infectious Diseases 2005 41 12 1772 1782 (Pubitemid 41759864)
8. Kwan C., Ernst J. D., HIV and tuberculosis: a deadly human syndemic Clinical Microbiology Reviews 2011 24 2 351 376
9. Abdool Karim S. S., Naidoo K., Grobler A., Padayatchi N., Baxter C., Gray A., Gengiah T., Nair G., Bamber S., Singh A., Khan M., Pienaar J., El-Sadr W., Friedland G., Abdool Karim Q., Timing of initiation of antiretroviral drugs during tuberculosis therapy The New England Journal of Medicine 2010 362 8 697 706
10. Blanc F.-X., Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis Proceedings of the International AIDS Conference 2010 Vienna, Austria. abstract no. THLBB0106
11. Girardi E., Antonucci G., Vanacore P., Palmieri F., Matteelli A., Iemoli E., Carradori S., Salassa B., Pasticci M. B., Raviglione M. C., Ippolito G., Babudieri S., Bassetti M., Rosso R., Carbonara S., Celesia B. M., Chirianni A., Di Perri G., Fabietti P., Gabutti A., Guadagnino V., Manfrin V., Pasticci M. B., Zacchini F., Burzacchini F., Giacometti A., Tassara A., Traverso A., Giorni P., Gobbi M., Mariani R., Di Gennaro G., Panella L., Losappio R., Beltrami C., Costigliola P., Fasulo G., Moling O., Bertelli D., Tedoldi S., Potenza D., Manconi P. E., Zichichi S., Nacca C., Fatuzzo F., La Rosa R., Galvagna S., Grosso C., Vecchiet J., Longoni E., Guaglianone L., Pan A., Pellican S., Raineri G., Ferrara S., Anzalone E., Gallo A., Cataldini S., Dodi F., Petronio A., Salone G., De Luca Andrioli E. P., De Checchi G., Villa M., Pardelli R., Tardio A., Urbani C., Gattuso G., Matini L., Casciano G., Loschiavo F., Errante I., Giani G., Meraviglia P., Molteni C., Guaraldi G., Foresti S., Abbrescia N., Izzo C., Filippini P., Noce S., Dalle Nogare E. R., Farinella E., Sacchi P., Scudeller L., Petrelli E., Alterio L., Paolillo F., Savalli E., Doria R., Catalani M., Brizzi M., Storaci N., Natalini Raponi G. P., Martelli L. T., Grisetti S., Lanini S., Palmieri F., Santopadre P., Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy European Respiratory Journal 2004 24 1 11 17 (Pubitemid 39036123)
12. World Health Organization, Treatment of Tuberculosis. Guidelines for National Programmes. Document WHO/CDS/TB 2003/313, World Health Organization, Geneva, Switzerland, 2003
13. Falzon D., Le Strat Y., Belghiti F., Infuso A., Exploring the determinants of treatment success for tuberculosis cases in Europe International Journal of Tuberculosis and Lung Disease 2005 9 11 1224 1229 (Pubitemid 41735601)
14. Faustini A., Hall A. J., Perucci C. A., Tuberculosis treatment outcomes in Europe: a systematic review European Respiratory Journal 2005 26 3 503 510 (Pubitemid 41264216)
15. Cayl J. A., Caminero J. A., Rey R., Lara N., Vallés X., Galds-Tangis H., Current status of treatment completion and fatality among tuberculosis patients in Spain International Journal of Tuberculosis and Lung Disease 2004 8 4 458 464 (Pubitemid 38624855)
16. World Health Organization, Treatment of Tuberculosis: Guidelines 2009 4th Geneva, Switzerland World Health Organization. Document WHO/HTM/TB/2009.420
17. Kaufmann G. R., Elzi L., Weber R., Furrer H., Giulieri S., Vernazza P., Bernasconi E., Hirschel B., Battegay M., Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death AIDS 2011 25 4 441 451
18. Komati S., Shaw P. A., Stubbs N., Mathibedi M. J., Malan L., Sangweni P., Metcalf J. A., Masur H., Hassim S., Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa AIDS 2010 24 12 1849 1855
19. Meintjes G., Rabie H., Wilkinson R. J., Cotton M. F., Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome and Unmasking of Tuberculosis by Antiretroviral Therapy Clinics in Chest Medicine 2009 30 4 797 810
20. Manabe Y. C., Breen R., Perti T., Girardi E., Sterling T. R., Unmasked tuberculosis: part of a disease spectrum after highly active antiretroviral therapy Journal of Infectious Diseases 2009 199 437 444